GlobeNewsWire: Genenta’s Temferon™: Evidence of Controlled and Targeted Interferon Expression in Preliminary Phase I/II Clinical Data in Glioblastoma Multiforme Posted on November 16, 2020 by genenta
GlobeNewswire: Genenta to present preliminary Phase I/II clinical data on Temferon™ in glioblastoma multiforme at Chardan’s 4th Annual Genetic Medicines Conference Posted on October 1, 2020 by genenta
Come viene prodotto un farmaco? Carlo Russo, MD, CMO&Head of Development, Genenta Posted on May 5, 2020May 5, 2020 by genenta
QN_Economia&Lavoro, Genenta Science è la migliore startup d’Italia Posted on December 23, 2019December 23, 2019 by genenta
Nanhaitoday, Genenta Science won the First Price at China-Italy Best StartUp Showcase and Entrepreneurship Competition 2018/2019 (BSSEC) in Foshan (China) Posted on December 2, 2019 by genenta